INmune Bio Market Cap

INmune Bio has a market cap or net worth of $61.15 million as of July 8, 2025. Its market cap has decreased by -59.86% in one year.

Market Cap

61.15M

Enterprise Value

42.16M

1-Year Change

-59.86%

Ranking

#4417

Market Cap Chart

Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $61.15M, a decrease of -21.43%. That is a compound annual growth rate of -3.68%.

Market Cap History

Date	Market Cap	% Change
Jul 8, 2025	61.15M	-40.95%
Dec 31, 2024	103.55M	-48.97%
Dec 29, 2023	202.92M	78.35%
Dec 30, 2022	113.78M	-37.49%
Dec 31, 2021	182.00M	-21.41%
Dec 31, 2020	231.57M	270.69%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	710.11B
Johnson & Johnson	375.44B
AbbVie	339.17B
Novo Nordisk	308.12B
UnitedHealth Group	277.87B
Novartis AG	240.05B
Abbott Laboratories	233.14B
AstraZeneca	216.19B

Market Cap Rankings